Conservative therapy of benign uterine bleeding; with special reference to the use of ergot

California medicine · 1953 · vol. 79(2) , pp. 103–4 · PMID:13067023 · PMC1521989
Other OA: closed
📄 Open PDF View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-14 ⓘ

This paper evaluates conservative therapies for benign uterine bleeding, noting that long-term Ergotrate administration yields good results without severe side effects, while diagnostic curettage or antibiotics address cases involving structural causes or infection.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Although operation frequently is carried out in cases of excessive uterine bleeding of benign origin, particularly if fibrous tumor is present, in many cases major surgical intervention could be averted by adequate conservative therapy. The authors have given Ergotrate(R) over long periods with good results in many cases and have noted no severe side effects. If this therapy fails, diagnostic dilatation and curettement sometimes reveals and removes the cause of bleeding. If infection is a factor, use of sulfonamides or antibiotics sometimes has dramatic effect.

My notes (saved in your browser only)

MeSH descriptors

Anti-Bacterial Agents Antibiotics, Antitubercular Cardiovascular Agents Curettage Ergonovine Ergot Alkaloids Menorrhagia Metrorrhagia Neoplasms, Fibrous Tissue Oxytocics Sulfonamides Ergot Alkaloids Female Humans Menorrhagia Metrorrhagia Sulfanilamide Sulfanilamides

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:01:19.120492+00:00